In a mouse model of allergic rhinitis, treatment with anti-IL-33 significantly reduced nose scratching events, brought about an apparent improvement in skin exfoliation symptoms, and diminished the degree of eosinophil infiltration. Here, IL33 is linked to allergic rhinitis.